Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice

The article focuses on differential choice of ACE inhibitor in clinical practice. Mechanisms of action common for all drugs in this group, indications and benefits are described. Differences in pharmacokinetic features, RAAS blockade, additional unique attributes, indications and strength of evidenc...

Full description

Bibliographic Details
Main Authors: O. D. Ostroumova, G. N. Schukina, V. M. Fomina
Format: Article
Language:Russian
Published: Remedium Group LLC 2013-12-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/1102
id doaj-b79093881f5b408792f414d7d129f4fe
record_format Article
spelling doaj-b79093881f5b408792f414d7d129f4fe2021-07-28T13:29:14ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902013-12-0109444910.21518/2079-701X-2013-9-44-491102Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choiceO. D. Ostroumova0G. N. Schukina1V. M. Fomina2MSUMD named after A.I. Evdokimov, First MSMU named after I.M.SechenovMSUMD named after A.I. Evdokimov, First MSMU named after I.M.SechenovMSUMD named after A.I. Evdokimov, First MSMU named after I.M.SechenovThe article focuses on differential choice of ACE inhibitor in clinical practice. Mechanisms of action common for all drugs in this group, indications and benefits are described. Differences in pharmacokinetic features, RAAS blockade, additional unique attributes, indications and strength of evidence for the class representative ramipril are highlighted. There is clinical data of Russian studies on anti-hypertensive effectiveness and anti-atherosclerotic properties of Hartil® (ramipril,"EGIS", Hungary).https://www.med-sovet.pro/jour/article/view/1102hypertensionatherosclerosiscoronary heart diseasestrokeace inhibitorsramipril
collection DOAJ
language Russian
format Article
sources DOAJ
author O. D. Ostroumova
G. N. Schukina
V. M. Fomina
spellingShingle O. D. Ostroumova
G. N. Schukina
V. M. Fomina
Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice
Медицинский совет
hypertension
atherosclerosis
coronary heart disease
stroke
ace inhibitors
ramipril
author_facet O. D. Ostroumova
G. N. Schukina
V. M. Fomina
author_sort O. D. Ostroumova
title Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice
title_short Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice
title_full Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice
title_fullStr Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice
title_full_unstemmed Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice
title_sort angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. how to make the right choice
publisher Remedium Group LLC
series Медицинский совет
issn 2079-701X
2658-5790
publishDate 2013-12-01
description The article focuses on differential choice of ACE inhibitor in clinical practice. Mechanisms of action common for all drugs in this group, indications and benefits are described. Differences in pharmacokinetic features, RAAS blockade, additional unique attributes, indications and strength of evidence for the class representative ramipril are highlighted. There is clinical data of Russian studies on anti-hypertensive effectiveness and anti-atherosclerotic properties of Hartil® (ramipril,"EGIS", Hungary).
topic hypertension
atherosclerosis
coronary heart disease
stroke
ace inhibitors
ramipril
url https://www.med-sovet.pro/jour/article/view/1102
work_keys_str_mv AT odostroumova angiotensinconvertingenzymeinhibitorsintreatmentpracticesimilarityanddifferencehowtomaketherightchoice
AT gnschukina angiotensinconvertingenzymeinhibitorsintreatmentpracticesimilarityanddifferencehowtomaketherightchoice
AT vmfomina angiotensinconvertingenzymeinhibitorsintreatmentpracticesimilarityanddifferencehowtomaketherightchoice
_version_ 1721274757295374336